MedTrace Logo

Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment

NCT03369925 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-02-27

No results posted yet for this study

Summary

The objective of this trial is to determine the effects of citicoline on cognitive performance in healthy Men and Women with Age-Associated Memory Impairment compared to a placebo.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Placebo supplement

Cellulose

DIETARY_SUPPLEMENT

Citicoline supplement

Cognizin

Sponsors & Collaborators

  • Biofortis Clinical Research, Inc.

    collaborator INDUSTRY

  • Kyowa Hakko Bio Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-02
Primary Completion
2018-12-03
Completion
2018-12-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03369925 on ClinicalTrials.gov